Mitchell P. Kopin 13D and 13G filings for Dermata Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-01-02 4:54 pm Purchase | 2025-12-24 | 13G | Dermata Therapeutics, Inc. DRMA | Mitchell P. Kopin | 147,059 5.500% | 144,725 (+6200.73%) | Filing |
| 2025-05-09 4:04 pm Sale | 2025-03-31 | 13G | Dermata Therapeutics, Inc. DRMA | Mitchell P. Kopin | 2,334 0.400% | -23,913 (-91.11%) | Filing |
| 2025-01-28 5:25 pm Purchase | 2025-01-23 | 13G | Dermata Therapeutics, Inc. DRMA | Mitchell P. Kopin | 26,247 6.700% | 26,247 (New Position) | Filing |